Investor Relations

DNAsequence SRL → Investor Relations

Investor Relations

We are a biotechnology company dedicated to developing and commercializing novel solutions. We have an advanced bioinformatics platform to accelerate the sampling to results process.

Corporate Presentation

Corporate Fact Sheet

ELOT EN ISO/IEC 17025:2017 Hellenic Accreditation System

ISO 27001:2013 Swiss Approval Technische Bewertung SA

EN ISO 9001:2015 Research & Development of Biotechnology / Bioinformatics Applications

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings ACCEPT

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT